CAMBRIDGE, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA), a leader in cell therapies for the treatment of advanced solid tumors, today announced the addition of Jerome ...

Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug discovery program targeting ATR.

Since the “Saharan Gold Rush” in the 1990s, one researcher has been fighting for the North African country’s contributions to ...

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing cancer therapies based on DNA-damage response ...

SES AI's novel electrolyte molecule, driven by AI technology, is revolutionizing the battery market with its safety and ...

planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good ...

Dubai World Trade Centre (DWTC) has announced its action-packed February events calendar, featuring 12 high profile events at ...

In the latest iteration of See Your Risks, Bayer takes aim at denial among millennials and Gen Xers when it comes to heart ...

Dubai World Trade Centre (DWTC) has announced its action-packed February events calendar, featuring 12 high profile events at ...

Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO) has granted the nonproprietary name ...